Allele-dose association of the C5orf30 rs26232 variant with joint damage in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 65, Issue 10, 2013, Pages 2555-2561

  Teare, M Dawn ^a   Knevel, Rachel ^b   Morgan, Michael D ^c   Kleszcz, Agnieszka ^a   Emery, Paul ^d   Moore, David J ^a   Conaghan, Philip ^d   Huizinga, Tom W J ^b   Morgan, Ann W ^d   Van Der Helm Van Mil, Annette H M ^b   Wilson, Anthony G ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; C5ORF30 GENE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; INJURY SEVERITY; JOINT INJURY; JOINT RADIOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARTHRITIS, RHEUMATOID; CARRIER PROTEINS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; FOOT JOINTS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GREAT BRITAIN; HAND JOINTS; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 84885125523     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.38064     Document Type: Article

References (28)

1. Odegard S, Landewe R, van der Heijde D, Kvien TK, Mowinckel P, Uhlig T,. Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients. Arthritis Rheum 2006; 54: 68-75.
2. Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, Kloppenburg M, de Vries RR, le Cessie S, et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 2006; 65: 366-71.
3. Maxwell JR, Gowers IR, Moore DJ, Wilson AG,. Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis. Rheumatology (Oxford) 2010; 49: 2140-6.
4. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010; 42: 508-14.
5. Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, Guiducci C, et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 2009; 41: 1313-8.
6. Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, et al. Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. Nat Genet 2008; 40: 1156-9.
7. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661-78.
8. Plant MJ, Williams AL, O'Sullivan MM, Lewis PA, Coles EC, Jessop JD,. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum 2000; 43: 1473-7.
9. Verstappen SM, Poole AR, Ionescu M, King LE, Abrahamowicz M, Hofman DM, et al. Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis. Arthritis Res Ther 2006; 8: R31.
10. Van der Helm-van Mil AH, Kern M, Gregersen PK, Huizinga TW,. Variation in radiologic joint destruction in rheumatoid arthritis differs between monozygotic and dizygotic twins and pairs of unrelated patients. Arthritis Rheum 2006; 54: 2028-30.
11. Knevel R, Grondal G, Huizinga TW, Visser AW, Jonsson H, Vikingsson A, et al. Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study. Ann Rheum Dis 2012; 71: 707-9.
12. Weyand CM, Xie C, Goronzy JJ,. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992; 89: 2033-9.
13. Mewar D, Marinou I, Coote AL, Moore DJ, Akil M, Smillie D, et al. Association between radiographic severity of rheumatoid arthritis and shared epitope alleles: differing mechanisms of susceptibility and protection. Ann Rheum Dis 2008; 67: 980-3.
14. Van der Linden MP, Feitsma AL, le Cessie S, Kern M, Olsson LM, Raychaudhuri S, et al. Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. Arthritis Rheum 2009; 60: 2242-7.
15. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 2007; 357: 1199-209.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
17. Larsen A, Dale K, Eek M,. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977; 18: 481-91.
18. Mewar D, Coote A, Moore DJ, Marinou I, Keyworth J, Dickson MC, et al. Independent associations of anti-cyclical citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis. Arthritis Res Ther 2006; 8: R128.
19. De Rooy DP, van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH,. Predicting arthritis outcomes-what can be learned from the Leiden Early Arthritis Clinic? Rheumatology (Oxford) 2011; 50: 93-100.
20. Van der Heijde DM,. How to read radiographs according to the Sharp/van der Heijde method [corrected and republished in J Rheumatol 2000;27:261-3]. J Rheumatol 1999; 26: 743-5.
21. Conaghan PG, Hensor EM, Keenan AM, Morgan AW, Emery P,. Persistently moderate DAS-28 is not benign: loss of function occurs in early RA despite step-up DMARD therapy. Rheumatology (Oxford) 2010; 49: 1894-9.
22. Plant D, Bowes J, Potter C, Hyrich KL, Morgan AW, Wilson AG, et al. Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci. Arthritis Rheum 2011; 63: 645-53.
23. Marinou I, Maxwell JR, Wilson AG,. Genetic influences modulating the radiological severity of rheumatoid arthritis. Ann Rheum Dis 2010; 69: 476-82.
24. Syversen SW, Gaarder PI, Goll GL, Odegard S, Haavardsholm EA, Mowinckel P, et al. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 2008; 67: 212-7.
25. Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T,. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005; 64: 196-201.
26. Wright KJ, Baye LM, Olivier-Mason A, Mukhopadhyay S, Sang L, Kwong M, et al. An ARL3-UNC119-RP2 GTPase cycle targets myristoylated NPHP3 to the primary cilium. Genes Dev 2011; 25: 2347-60.
27. Gorska MM, Stafford SJ, Cen O, Sur S, Alam R,. Unc119, a novel activator of Lck/Fyn, is essential for T cell activation. J Exp Med 2004; 199: 369-79.
28. Knevel R, de Roog DP, Gregersen PK, Lindqvist E, Wilson AG, Gröndal G, et al. Studying associations between variants in TRAF1-C5 and TNFAIP3-OLIG3 and the progression of joint destruction in rheumatoid arthritis in multiple cohorts. Ann Rheum Dis 2012; 71: 1753-5.